Mandate

Vinge’s Forensic, Risk & Compliance Group assists Tele2

Tele2 has decided to leave Kazakhstan and has today published the terms and conditions governing the transaction.

In connection with the exit, Tele2 has issued the extensive report "Tele2 Kazakhstan - Exit Report on Ethics and Compliance". The Exit Report is part of Tele2’s obligation to act ethically, to fight corruption and be transparent to shareholders and the market. 
 
Vinge’s Forensic, Risk & Compliance Group has assisted Tele2 in conjunction with the company’s analysis and reporting of the anti‑corruption work which Tele2 has conducted since it arrived in Kazakhstan. In the Exit Report, Tele2 describes its method of identifying and addressing corruption risks. This method is based on Vinge’s formulated best practice – a compliance programme consisting of 10 steps which companies and organizations should implement in order to prevent bribery and corruption in their business operations. 

“It is very satisfying to work with a company which takes the risks of corruption seriously. It is not possible to prevent everything, although you can establish a framework and procedures which minimize the risk significantly”,

says Mia Falk, Head of Forensic, Risk & Compliance at Vinge.

For more information, please see Tele2’s press release as well as Tele2 Kazakhstan - Exit Report on Ethics and Compliance

Vinge’s team consisted of Mia Falk and Hayaat Ibrahim.

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025